drugset / Trial / NCT05417321
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
NaSequentialOpen-labelTreatment
Summary
It is a Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HB0036 in Subjects with Advanced Solid Tumors
Timeline
- Start
- 2022-08-25
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HB0036 | Unknown | — | Intravenous |